• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    New insight of vitamin D in chronic liver diseases

    2014-05-04 09:38:13EnQiangChenYingShiandHongTang

    En-Qiang Chen, Ying Shi and Hong Tang

    Chengdu, China

    New insight of vitamin D in chronic liver diseases

    En-Qiang Chen, Ying Shi and Hong Tang

    Chengdu, China

    BACKGROUND:Vitamin D is a fat-soluble sterol derivative that is predominantly synthesized in the liver and has multiple functions. The accumulative data showed that the clinical manifestations and prognosis of chronic liver diseases are associated with serum vitamin D levels.

    DATA SOURCES:A PubMed and Google Scholar search using terms: "vitamin D", "25(OH)D", "liver disease", "viral hepatitis", "non-alcoholic fatty liver disease", "liver fibrosis", "cirrhosis", "hepatocellular carcinoma" and "autoimmune liver disease" was performed, and relevant articles published in English between January 2000 and March 2014 were reviewed. Fulltext publications relevant to the field were selected and relevant articles from reference lists were also included.

    RESULTS:The insufficiency or deficiency of vitamin D is common in various kinds of chronic liver diseases including viral hepatitis B and C. Serum 25-hydroxyvitamin D and vitamin D receptors are possibly interrelated with the incidence, treatment and prognosis of diseases. Though the evidence of vitamin D supplementation in viral hepatitis and associated liver diseases is still limited, there is great potential to apply this adjuvant therapy to improve the treatments.

    CONCLUSIONS:Although the exact role and mechanisms of vitamin D have not been fully elucidated in chronic liver diseases, it is potentially beneficial in the treatment of chronic liver diseases. Further mechanistic studies are needed to validate its clinical application.

    (Hepatobiliary Pancreat Dis Int 2014;13:580-585)

    vitamin D;

    deficiency;

    viral hepatitis;

    chronic liver diseases

    Introduction

    Vitamin D, the sunshine vitamin, is now recognized not only for its importance of bone health in humans,[1]but also for other health benefits including reducing the risk or progression of chronic liver diseases (CLDs). Vitamin D produced in the skin or ingested in the diet is biologically inert and requires two successive hydroxylations first in the liver on carbon 25 to form 25-hydroxyvitamin D [25(OH)D], and then in the kidney for a hydroxylation on carbon 1 to form the most important biologically active form of vitamin D, 1, 25-dihydroxyvitamin D [1, 25(OH)2D].[2]It is worthy to mention that extra renal hydroxylation of 25(OH)D is also important for the non-skeletal actions of vitamin D, because 1, 25(OH)2D controls a variety of genes directly or indirectly to regulate cellular proliferation, differentiation, apoptosis and angiogenesis.[3]

    In the past decades, methods have been developed to measure serum 25(OH)D and 1, 25(OH)2D concentrationsin vivo. In recent years, lots of evidences suggest that serum 25(OH)D is the best indicator of vitamin D statusin vivo;[4]while serum 1, 25(OH)2D provides limited information about vitamin D status, because it is often normal or even elevated due to secondary hyperparathyroidism associated with vitamin D deficiency. So serum 25(OH)D examination now has been widely used to evaluate vitamin D concentrations in clinical practice.[4]

    Clinical and epidemiological data have shown that chronic viral hepatitis and their extrahepatic manifestations are associated with lower vitamin D concentrations.[5]In recent years, there has been considerable speculation about the potential role of vitamin D in the treatment of CLD patients with low serum vitamin D levels.[6,7]It is encouraging that the therapeutic value of vitamin D supplement has been confirmed in autoimmune liver diseases.[8,9]And a recent study[10]also showed the association between vitamin D shortage and the severity of chronic viral hepatitis, non-alcoholic fatty liver disease (NAFLD) and other CLDs. In this review, we briefly summarize thenew progress of factors affecting vitamin D deficiency in common CLDs and the correlation of viral hepatitis and other CLDs with reduced serum 25(OH)D concentrations.

    Factors associated with vitamin D deficiency

    Serum 25(OH)D concentration is an objective variable reflecting vitamin D restoration in body, but there is no exact definition of its normal range in real clinical setting. In general population, the normal concentration of serum 25(OH)D is 75-120 nmol/L (30-50 ng/mL), inadequate concentration is 50-75 nmol/L (20-30 ng/ mL), while shortage concentration is less than 50 nmol/ L (<20 ng/mL); and there is no difference between male and female populations. According to this standard, approximately one billion people worldwide are vitamin D inadequate or shortage.

    Most scholars believe that the lack of sun ultraviolet exposure is the main cause of vitamin D insufficiency, because air pollution induced by modern industry retard the necessary ultraviolet radiation which is essential for vitamin D synthesis.[11]Currently, modern lifestyle habits also play a pivotal role in vitamin D inadequate or shortage. To prevent skin aging or cancer, sun umbrella and sunscreen cosmetics are intentionally utilized to stay away from sunshine. The prolongation of life span is another factor of vitamin D deficiency, vitamin D synthesis in skin and absorption by intestinal tract declines along with increasing age.[11]Additionally, the vitamin D content in modern fortified foods is significantly less than that in wild oily marine fish, freshwater fish, cod liver oil, egg yolk and so on. In recent years, high heritability suggests that genetic factors could also play a role in vitamin D deficiency.[12,13]For example, variants genes involved in cholesterol synthesis, hydroxylation, and vitamin D transport affect vitamin D status; and genetic variation at these loci identifies individuals who have substantially raised risk of vitamin D insufficiency.[12]

    The distribution of the vitamin D in the body also affects the serum levels. Serum 25(OH)D is often decreased in obese people because of the retaining of vitamin D in adipose tissue. The vitamin D retaining capability of the adipose tissue is the same and therefore, the vitamin D is diluted in people with obese, leading to the decrease of serum vitamin D. The weight loss caused by malabsorption may also lower the serum vitamin D level. As there is no feedback regulation of hydroxylation of vitamin D in the liver, when liver parenchyma disease occurs, impaired hydroxylation of vitamin D can also lead to vitamin D deficiency or shortage.[14,15]A genetic study[12]showed that vitamin D related gene polymorphisms, including vitamin D-binding protein (DBP), vitamin D receptor (VDR) and α1 hydroxylase gene, are associated with serum vitamin D concentrations.

    Viral hepatitis

    Clinical evidence indicated that patients with chronic hepatitis C (CHC) are always at higher risk of vitamin D deficiency.[16]In a large scale study,[17]serum 25(OH)D in CHC patients was significantly lower than that in healthy population (25.07±9.92 vs 43.06±10.19 ng/mL, P<0.0001), and serum 25(OH)D was less than 30 ng/mL in 73% of CHC patients whereas only 6% in the healthy controls. Current evidence[17,18]suggested that HCV not only inhibits 25(OH)D synthesis by regulating lipid metabolism, but also decreases the production of previtamin D, which is an intermediate in the cascades of 1, 25(OH)2D synthesis.[19]Low serum 25(OH)D level is associated with the severity of liver diseases and fibrosis damage in CHC patients.[20,21]

    Serum 25(OH)D deficiency is associated with the severity of liver diseases in human immunodeficiency virus (HIV)/HCV co-infected patients,[10,22]and lower serum 25(OH)D may also impair virological response to pegylated interferon α (PEG-IFNα) and ribavirin (RBV) therapy in those HIV/HCV co-infected patients.[23]The low level of serum vitamin D may negatively affect the virological response of PEG-IFNα/ RBV, and appropriate vitamin D supplement would improve sustained virological response in CHC and HIV/ HCV co-infected patients.[22,23]Gal-Tanamy et al[24]suggested that vitamin D inhibits HCV RNA replication directly, possessing natural antiviral activity, and its collaborative antiviral effect with interferon improves antiviral effect in CHC patients.[6,25]Kondo et al[26]reported that 1, 25(OH)2D supplement improves the sensitivity of PEG-IFNα/RBV therapy on HCV-infected hepatocytes by reducing the IP-10 production from PBMCs and ISGs expression in the liver. Additionally, the beneficial effect of vitamin D on decreasing insulin resistance and improving systemic inflammation may also contribute to the virological response of PEGIFNα/RBV therapy in CHC patients.[6,27,28]These data indicate that CHC patients with low serum vitamin D need to supply this vitamin when they are treated with PEG-IFNα/RBV.[29]It is worthy to mention that serum DBP and the polymorphism of DBP are known to influence vitamin D levels; and in difficult-to-treat HCV genotypes, simultaneous pretreatment normal serum vitamin D levels and the carriage of DBP wild-type isoform strongly predicts the achievement of sustained virological response after PEG-IFNα/RBV antiviraltherapy.[30]

    New evidence continues to suggest a relationship between serum vitamin D level and chronic hepatitis B (CHB). Farnik et al[31]quantitatively examined the levels of serum 25(OH)D in 203 untreated CHB patients, and found that there were 34% patients with severe vitamin deficiency (<10 ng/mL), 47% with vitamin D insufficiency, and only 19% with normal level. Whereas vitamin D level in HBeAg positive patients is notably lower than that in HBeAg negative patients. Meanwhile, vitamin D level presents opposite seasonal fluctuations compared with HBV DNA, and the low level of serum 25(OH)D is correlated with high HBV DNA.[31]Though, it is still uncertain whether the low level of serum vitamin D decreases the efficacy of PEG- IFNα or nucleos(t)ide analogs, some scholars speculated that appropriate vitamin D supplement may be helpful to improve or optimize curative efficacy of existing antiviral therapy for CHB patients with vitamin D deficiency. Because of the huge amount of CHB patients all over the world and the relative limited therapeutic drugs and antiviral strategies, it is very important and necessary to recognize the role of vitamin D in CHB progression, and potential value for increasing the antiviral efficacy of existing antiviral therapy and developing new targets for antiviral treatment in the future.

    NAFLD

    The morbidity of NAFLD is on the rise worldwide, and epidemiological data showed that NAFLD morbidity is significantly higher in the vitamin D deficiency population than that in normal subjects; similarly, NAFLD patients tend to have a lower vitamin D level.[32-34]

    Nakano and coworkers[35]reported that in an animal study the lower level of vitamin D is associated with obesity and severity of liver steatosis, indicating that vitamin D deficiency may participate in NAFLD progression. Vitamin D deficiency may also up-regulate hepatic inflammation and oxidative stress genes via endotoxin and Toll-like receptor pathway to cause NAFLD.[36]Considering the significance of insulin resistance in NAFLD development,[37]the correlation between vitamin D deficiency and insulin resistance might be another important cause of the progression of NAFLD, as low vitamin D level is associated with the impaired function of islet beta cells.[38]Interestingly, current preclinical studies demonstrated that sunlight exposure and vitamin D supplements helped to ameliorate NAFLD histopathology. Kitson and Roberts[39]proposed that vitamin D plays an important role in the activation and regulation of both innate and adaptive immune systems, which indicate the beneficial effect of vitamin D on NAFLD. Although the exact mechanism is still not clear, we believe that vitamin D is an effective drug in the prevention and treatment of NAFLD.

    Liver fibrosis and cirrhosis

    Due to the severe liver functional damage, the construction of transport proteins in patients with fibrosis and cirrhosis is decreased. Thus, vitamin D de ficiency is very common in these patients. In HIV/ HCV co-infected patients, serum 25(OH)D levels are signi ficantly correlated with the Metavir fibrosis score; and patients with severe fibrosis (Metavir F3/F4) have lower serum 25(OH)D levels compared with F2 and F1 patients (16.2 ± 10.0 vs 18.9±8.5 and 20.9±11.1 ng/ mL, respectively).[22]In genotype I CHC patients, lower serum vitamin D levels are signi ficantly associated with the severity of liver fibrosis,[17]and correction of vitamin D de ficiency in patients with CLD is a potential therapy to inhibit progression of fibrosis, as 1, 25(OH)2D and its nuclear receptor repress human α1(I) collagen expression and type I collagen formation.[40]Indeed, those clinical findings are also supported by in vitro and in vivo experiments, showing that 1, 25(OH)2D possesses antifibrosis effect both in bone marrow mesenchymal stem cells and fibrosis rat, with the increasing expression of VDR caused by 1, 25(OH)2D, which inhibit the proliferation of hepatic stellate cells and the expression of cyclin D1, tissue inhibitor of metalloproteinase 1 and collagen.[41]In addition, vitamin D is also able to reduce the production of body smooth muscle actin and collagen, thus inhibiting the progression of liver cirrhosis induced by thioacetamide. All those clues strongly suggest that vitamin D is most likely to be an anti-fibrosis agent.[42]

    In the past years, genome-wide studies have identified genetic variants (including DHCR7, CYP2R1 and DBP) that affect serum 25(OH)D levels in healthy populations; and GG homozygosis for DHCR7 gene and lower 25(OH)D levels in CHC patients are both independently associated with the severity of liver fibrosis.[43]Grünhage et al[44]also reported that the common variation in 25(OH)D metabolism is associated with liver stiffness in patients with CLD, and the stronger influence of 25(OH)D is on the initiation rather than progression of hepatic fibrosis. Moreover, the low level of VDR is also an important factor affecting fibrosis,[45]and VDR gene polymorphism is significantly linked with fibrosis and cirrhosis progression,[46]including the presence of cirrhosis in CHC patients.[21]

    Hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is the sixth mostcommon cancer in the world, approximately 630 000 new cases are diagnosed each year. Amany them, 82% of the cases are related to viral hepatitis, 55% to HBV; but 89% of the cases are in regions where HBV is endemic.[47]

    There is a correlation between the progressive decline of active vitamin D and the progression of liver disease. Genetic analyses also revealed a role for vitamin D insufficiency in HCV-associated HCC development.[48]Thus, some researchers[49]proposed that serum vitamin D is also a potential biomarker of HCC, just like serum α-fetoprotein, and that vitamin D may be valuable for monitoring HCC in patients with high-risk, including those with CHB or CHC. In addition, vitamin D deficiency is common in HCC patients after liver transplantation and is closely related to prognosis, thus serum vitamin D levels also may be a prognostic indicator for HCC after treatment, and vitamin D supplementation may help to prevent acute cellular rejection in liver recipients with severe vitamin D deficiency.

    Though current epidemiological data are not enough to completely uncover the correlation between vitamin D and HCC, lots of experimental evidences suggested that vitamin D and its analogs (such as EB1089 and seocalcitol) have inhibitory effect against HCC cell lines.[50-52]Active 1, 25(OH)2D has anti-tumor effects in several aspects, including anti-proliferation, antiinflammatory, anti-angiogenesis, promoting apoptosis and differentiation.[51,53,54]Moreover, DBP-macrophage activating factor activates macrophages, the latter has anti-angiogenic activity and tumor killing activity, which inhibit HCC growth.[55]All of the data above implied that vitamin D and vitamin D-related molecules may represent a new strategy for the treatment of HCC.

    Autoimmune liver disease

    The development of autoimmune disease is based on the interaction of genetic susceptibility and environmental causes. Vitamin D endocrine system plays important roles in host immune system responses. For example, activated macrophages (a type of immune cell) not only produce 1, 25(OH)2D, but also express VDR.[56]And the liverproduced 1, 25(OH)2D could further activate a negative feed-back loop at sites of inflammation and therefore contribute to the suppression of the occurrence of autoimmune liver disease.[56]

    Actually, the active vitamin D acts its biological effects by binding to its own receptor VDR; and vitamin D also modulates the expression of VDR in human bile duct epithelial cells. D'Aldebert et al[57]demonstrated that biliary epithelial cells in human liver expressed both cathelicidin and VDR, and that VDR is also an important nuclear receptor for ursodeoxycholic acid (UDCA) inducing cathelicidin expression in biliary epithelial cells. Thus the hepatic expression of VDR increased the efficacy of UDCA therapy, and vitamin D and UDCA have synergistic effect on some autoimmune liver diseases such as primary biliary cirrhosis and primary sclerosing cholangitis.

    Recent studies[58,59]found that genetic factors appear to be involved in the pathogenesis of autoimmune liver diseases, and that VDR polymorphisms may be associated with autoimmune liver diseases such as autoimmune hepatitis and primary biliary cirrhosis. However, further studies are still needed to elucidate the mechanisms by which VDR polymorphisms contribute to the losing of immune tolerance in autoimmune diseases.

    Summary

    Vitamin D, along with its related VDR, is possibly interrelated with the incidence, treatment and prognosis of a variety of chronic liver diseases. Though the exact role and mechanisms of vitamin D in viral hepatitis have not been fully elucidated and the evidence for vitamin D supplement in those populations is still limited, vitamin D supplement may potentially optimize the current treatment. The role of vitamin D in CLD needs further study.

    Contributors:TH proposed the study. CEQ and SY performed research and wrote the first draft. CEQ collected and analyzed the data. All authors contributed to the design and interpretation of the study and to further drafts. TH is the guarantor.

    Funding:This study was supported by grants from the National Twelve-Five Project of China (2012ZX10002007-001-003), and the Chinese Foundation for Hepatitis Prevention and Control-TianQing Liver Disease Research Fund (cfhpc20132047).

    Ethical approval:Not needed.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol 2013;5:51-108.

    2 Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2011;12:4-18.

    3 Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;26:662-687.

    4 Health Quality Ontario. Clinical utility of vitamin d testing: an evidence-based analysis. Ont Health Technol Assess Ser 2010;10:1-93.

    5 Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010;55:2624-2628.

    6 Bitetto D, Fabris C, Fornasiere E, Pipan C, Fumolo E, Cussigh A, et al. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl Int 2011;24:43-50.

    7 Han YP, Kong M, Zheng S, Ren Y, Zhu L, Shi H, et al. Vitamin D in liver diseases: from mechanisms to clinical trials. J Gastroenterol Hepatol 2013;28:49-55.

    8 Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80:1678S-1688S.

    9 Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M. Vitamin D in autoimmune liver disease. Clin Res Hepatol Gastroenterol 2013;37:535-545.

    10 Guzmán-Fulgencio M, García-álvarez M, Berenguer J, Jiménez-Sousa Má, Cosín J, Pineda-Tenor D, et al. Vitamin D deficiency is associated with severity of liver disease in HIV/ HCV coinfected patients. J Infect 2014;68:176-184.

    11 Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol 2011;91:115-124.

    12 Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010;376:180-188.

    13 Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010;19:2739-2745.

    14 Stokes CS, Volmer DA, Grünhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int 2013;33:338-352.

    15 Nair S. Vitamin d deficiency and liver disease. Gastroenterol Hepatol (N Y) 2010;6:491-493.

    17 Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010;51:1158-1167.

    18 Clark PJ, Thompson AJ, Vock DM, Kratz LE, Tolun AA, Muir AJ, et al. Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner. Hepatology 2012;56:49-56.

    19 Webb AR. Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol 2006;92:17-25.

    20 El Husseiny NM, Fahmy HM, Mohamed WA, Amin HH. Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus Egyptians. World J Hepatol 2012;4:242-247.

    21 Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, et al. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int 2012;32:635-643.

    22 Terrier B, Carrat F, Geri G, Pol S, Piroth L, Halfon P, et al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J Hepatol 2011;55:756-761.

    23 Mandorfer M, Reiberger T, Payer BA, Ferlitsch A, Breitenecker F, Aichelburg MC, et al. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients. AIDS 2013;27:227-232.

    24 Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, et al. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology 2011;54:1570-1579.

    25 Petta S, Ferraro D, Cammà C, Cabibi D, Di Cristina A, Di Marco V, et al. Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antivir Ther 2012;17:823-831.

    26 Kondo Y, Kato T, Kimura O, Iwata T, Ninomiya M, Kakazu E, et al. 1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial. PLoS One 2013;8:e63672.

    27 Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-na?ve patients. World J Gastroenterol 2011;17:5184-5190.

    28 Nimer A, Mouch A. Vitamin D improves viral response in hepatitis C genotype 2-3 na?ve patients. World J Gastroenterol 2012;18:800-805.

    29 Rahman AH, Branch AD. Vitamin D for your patients with chronic hepatitis C? J Hepatol 2013;58:184-189.

    30 Falleti E, Bitetto D, Fabris C, Fattovich G, Cussigh A, Cmet S, et al. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology 2012;56:1641-1650.

    30 Farnik H, Bojunga J, Berger A, Allwinn R, Waidmann O, Kronenberger B, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology 2013;58:1270-1276.

    32 Targher G, Scorletti E, Mantovani A, Byrne CD. Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels. Metab Syndr Relat Disord 2013;11:217-228.

    33 Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;38:246-254.

    34 Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, et al. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2013;23:792-798.

    35 Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 2011;55:415-425.

    36 Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology 2012;55:1103-1111.

    37 Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G. Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des 2010;16:1941-1951.

    38 Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, et al. Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes2011;60:2947-2953.

    39 Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol 2012;57:897-909.

    40 Potter JJ, Liu X, Koteish A, Mezey E. 1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1 (I) collagen expression and type I collagen formation. Liver Int 2013;33: 677-686.

    41 Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 2011;60:1728-1737.

    42 Song BJ, Rockey DC. Status of research on vitamin D supplementation in treating or preventing liver fibrosis. Liver Int 2013;33:653-655.

    43 Petta S, Grimaudo S, Marco VD, Scazzone C, Macaluso FS, Cammà C, et al. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Viral Hepat 2013;20:486-493.

    44 Grünhage F, Hochrath K, Krawczyk M, H?blinger A, Obermayer-Pietsch B, Geisel J, et al. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 2012;56:1883-1891.

    45 Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013;153:601-613.

    46 Tanaka A, Nezu S, Uegaki S, Kikuchi K, Shibuya A, Miyakawa H, et al. Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J Hepatol 2009;50:1202-1209.

    47 Michielsen P, Ho E. Viral hepatitis B and hepatocellular carcinoma. Acta Gastroenterol Belg 2011;74:4-8.

    48 Lange CM, Miki D, Ochi H, Nischalke HD, Bojunga J, Bibert S, et al. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PLoS One 2013;8:e64053.

    49 Hammad LN, Abdelraouf SM, Hassanein FS, Mohamed WA, Schaalan MF. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis? J Immunotoxicol 2013;10:380-386.

    50 Ghous Z, Akhter J, Pourgholami MH, Morris DL. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study. Anticancer Res 2008;28:3757-3761.

    51 Chiang KC, Yeh CN, Chen MF, Chen TC. Hepatocellular carcinoma and vitamin D: a review. J Gastroenterol Hepatol 2011;26:1597-1603.

    52 Dalhoff K, Dancey J, Astrup L, Skovsgaard T, Hamberg KJ, Lofts FJ, et al. A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer 2003;89:252-257.

    53 Guo J, Ma Z, Ma Q, Wu Z, Fan P, Zhou X, et al. 1, 25(OH)2D3inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes. Curr Med Chem 2013;20:4131-4141.

    54 Fingas CD, Altinbas A, Schlattjan M, Beilfuss A, Sowa JP, Sydor S, et al. Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinoma. Digestion 2013;87:176-181.

    55 Nonaka K, Onizuka S, Ishibashi H, Uto Y, Hori H, Nakayama T, et al. Vitamin D binding protein-macrophage activating factor inhibits HCC in SCID mice. J Surg Res 2012;172:116-122.

    56 Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 2003;49:277-300.

    57 D'Aldebert E, Biyeyeme Bi Mve MJ, Mergey M, Wendum D, Firrincieli D, Coilly A, et al. Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology 2009;136: 1435-1443.

    58 Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002;35:126-131.

    59 Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, et al. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol 2005;20:249-255.

    Received March 27, 2014

    Accepted after revision June 30, 2014

    Author Affiliations: Center of Infectious Diseases, West China Hospital; and Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China (Chen EQ, Shi Y and Tang H)

    Hong Tang, MD, PhD, Center of Infectious Diseases, West China Hospital; and Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China (Tel: +86-28-85422650; Fax: +86-28-85423052; Email: htang6198@hotmail. com)

    ? 2014, Hepatobiliary Pancreat Dis Int. All rights reserved.

    10.1016/S1499-3872(14)60295-2

    Published online August 21, 2014.

    一夜夜www| 欧美3d第一页| 免费一级毛片在线播放高清视频| 亚洲人成网站在线播放欧美日韩| 少妇被粗大猛烈的视频| 精品免费久久久久久久清纯| 免费在线观看成人毛片| 啦啦啦观看免费观看视频高清| 99视频精品全部免费 在线| 搡老岳熟女国产| 日韩强制内射视频| 日韩 亚洲 欧美在线| 国产精品永久免费网站| 中文资源天堂在线| 亚洲av免费在线观看| 欧美性猛交黑人性爽| 舔av片在线| 国内精品宾馆在线| 欧美一级a爱片免费观看看| 午夜视频国产福利| 国产精品乱码一区二三区的特点| av天堂在线播放| 人人妻人人澡欧美一区二区| 中文字幕熟女人妻在线| 久久99热6这里只有精品| 国产激情偷乱视频一区二区| 12—13女人毛片做爰片一| 亚洲av.av天堂| 少妇猛男粗大的猛烈进出视频 | 美女xxoo啪啪120秒动态图| 午夜爱爱视频在线播放| 欧美高清成人免费视频www| 成人毛片a级毛片在线播放| 久久久久久久久久黄片| 免费观看的影片在线观看| 久久精品国产亚洲av天美| 成人高潮视频无遮挡免费网站| 日本五十路高清| 丰满乱子伦码专区| 夜夜夜夜夜久久久久| 人人妻人人看人人澡| 1000部很黄的大片| 国产精品人妻久久久影院| 国模一区二区三区四区视频| 男女那种视频在线观看| 国产视频一区二区在线看| 九九久久精品国产亚洲av麻豆| 久久6这里有精品| 美女高潮的动态| 亚洲成av人片在线播放无| 大型黄色视频在线免费观看| 黄色视频,在线免费观看| 亚洲人与动物交配视频| 亚洲国产日韩欧美精品在线观看| 亚洲成人精品中文字幕电影| 丝袜美腿在线中文| 亚洲图色成人| 国产精品久久久久久久电影| 亚洲18禁久久av| 午夜免费激情av| 高清在线国产一区| 色哟哟哟哟哟哟| 国产亚洲91精品色在线| 一进一出抽搐动态| 在线国产一区二区在线| 亚洲国产精品sss在线观看| 欧美性感艳星| 男人狂女人下面高潮的视频| 网址你懂的国产日韩在线| 少妇丰满av| 久久久久久久精品吃奶| 中文字幕人妻熟人妻熟丝袜美| 国产精品98久久久久久宅男小说| 国产免费av片在线观看野外av| 成人午夜高清在线视频| 久久草成人影院| 亚洲va日本ⅴa欧美va伊人久久| 嫩草影视91久久| АⅤ资源中文在线天堂| 国产视频内射| 国产精品99久久久久久久久| 久久久成人免费电影| 毛片一级片免费看久久久久 | 91午夜精品亚洲一区二区三区 | 伦理电影大哥的女人| 国产不卡一卡二| 久久久久久久精品吃奶| av在线老鸭窝| 亚洲精品亚洲一区二区| 天美传媒精品一区二区| 日本在线视频免费播放| 久久精品91蜜桃| 亚洲av美国av| 国产中年淑女户外野战色| 赤兔流量卡办理| 国产精品久久久久久亚洲av鲁大| 免费大片18禁| 色尼玛亚洲综合影院| 亚洲专区国产一区二区| 亚洲av成人av| x7x7x7水蜜桃| 少妇熟女aⅴ在线视频| 男人舔奶头视频| 国内揄拍国产精品人妻在线| 欧美性猛交╳xxx乱大交人| 男女视频在线观看网站免费| xxxwww97欧美| 成人一区二区视频在线观看| 亚洲精品一卡2卡三卡4卡5卡| 人妻夜夜爽99麻豆av| 国产午夜精品久久久久久一区二区三区 | 毛片一级片免费看久久久久 | 赤兔流量卡办理| 白带黄色成豆腐渣| 97碰自拍视频| 哪里可以看免费的av片| 夜夜爽天天搞| 免费看av在线观看网站| 中文字幕av在线有码专区| av.在线天堂| 床上黄色一级片| 久9热在线精品视频| 少妇的逼水好多| 欧美日本亚洲视频在线播放| 日韩av在线大香蕉| 联通29元200g的流量卡| 99国产极品粉嫩在线观看| 狠狠狠狠99中文字幕| 别揉我奶头 嗯啊视频| 免费观看在线日韩| 日韩欧美免费精品| 真实男女啪啪啪动态图| 日日啪夜夜撸| 嫩草影院入口| 小蜜桃在线观看免费完整版高清| 亚洲自拍偷在线| 免费人成视频x8x8入口观看| 99热这里只有是精品50| 成人国产一区最新在线观看| 丝袜美腿在线中文| 免费一级毛片在线播放高清视频| 少妇被粗大猛烈的视频| 久久久国产成人免费| 中文字幕高清在线视频| avwww免费| 毛片女人毛片| 国产午夜精品论理片| 国产高清激情床上av| 桃红色精品国产亚洲av| 亚洲国产日韩欧美精品在线观看| 久久亚洲精品不卡| 亚洲成人久久爱视频| 伦精品一区二区三区| avwww免费| 国产亚洲精品久久久com| 欧美潮喷喷水| 国产 一区精品| 欧美黑人巨大hd| 亚洲av成人精品一区久久| 国产三级中文精品| 两个人视频免费观看高清| 九色国产91popny在线| 国产乱人视频| 午夜福利在线观看吧| 啦啦啦观看免费观看视频高清| 自拍偷自拍亚洲精品老妇| 欧美成人a在线观看| 成人美女网站在线观看视频| 日韩中字成人| 美女 人体艺术 gogo| 成人永久免费在线观看视频| 草草在线视频免费看| 成年人黄色毛片网站| 免费av观看视频| 国内揄拍国产精品人妻在线| 国产日本99.免费观看| 少妇高潮的动态图| 亚洲精品国产成人久久av| 婷婷丁香在线五月| 国产视频一区二区在线看| 亚洲精品国产成人久久av| 成人亚洲精品av一区二区| 免费观看在线日韩| 少妇裸体淫交视频免费看高清| 久久精品国产鲁丝片午夜精品 | 老司机午夜福利在线观看视频| 欧美区成人在线视频| 欧美日韩中文字幕国产精品一区二区三区| 一卡2卡三卡四卡精品乱码亚洲| 不卡一级毛片| 色播亚洲综合网| 亚洲欧美日韩高清在线视频| 久久精品夜夜夜夜夜久久蜜豆| 在现免费观看毛片| 白带黄色成豆腐渣| 亚洲精品国产成人久久av| 九九爱精品视频在线观看| 国产精品综合久久久久久久免费| 一个人观看的视频www高清免费观看| 亚洲欧美日韩高清在线视频| 草草在线视频免费看| 国产精品美女特级片免费视频播放器| 精品不卡国产一区二区三区| a级毛片免费高清观看在线播放| 99热这里只有精品一区| 男女啪啪激烈高潮av片| 99riav亚洲国产免费| 在线国产一区二区在线| 日韩欧美一区二区三区在线观看| 啦啦啦啦在线视频资源| 三级国产精品欧美在线观看| 校园人妻丝袜中文字幕| 午夜视频国产福利| 99久久精品热视频| 国产v大片淫在线免费观看| 三级国产精品欧美在线观看| 狠狠狠狠99中文字幕| 联通29元200g的流量卡| 国产精品,欧美在线| xxxwww97欧美| 悠悠久久av| 狠狠狠狠99中文字幕| 联通29元200g的流量卡| 亚洲av.av天堂| xxxwww97欧美| 亚洲中文字幕一区二区三区有码在线看| 免费大片18禁| 少妇的逼水好多| 日韩欧美一区二区三区在线观看| 蜜桃亚洲精品一区二区三区| 国产三级中文精品| 麻豆成人午夜福利视频| 亚洲人成网站在线播放欧美日韩| 亚洲国产精品成人综合色| 亚洲欧美日韩高清在线视频| 久久精品国产清高在天天线| 女人被狂操c到高潮| 国产一区二区三区视频了| 搡老妇女老女人老熟妇| 久久久久久久久中文| 黄片wwwwww| 国内精品宾馆在线| 女同久久另类99精品国产91| 久久久久久久精品吃奶| 国产午夜精品论理片| 亚洲美女黄片视频| 亚洲无线在线观看| 精品无人区乱码1区二区| 亚洲无线观看免费| 国产高清激情床上av| 免费观看的影片在线观看| 国产单亲对白刺激| 日韩人妻高清精品专区| 一本一本综合久久| 黄色日韩在线| 一区二区三区四区激情视频 | 99久久成人亚洲精品观看| 人人妻,人人澡人人爽秒播| 男人的好看免费观看在线视频| 欧美+日韩+精品| 精品久久久久久久久av| 久久久久久久亚洲中文字幕| 香蕉av资源在线| 久久久国产成人精品二区| 人妻夜夜爽99麻豆av| 精品久久久久久久末码| 搞女人的毛片| 久久久精品欧美日韩精品| 国产高清三级在线| 国产精品一及| 色尼玛亚洲综合影院| 日韩欧美精品v在线| 国产真实乱freesex| 精品不卡国产一区二区三区| 亚洲五月天丁香| 伦精品一区二区三区| 九色成人免费人妻av| 高清在线国产一区| 国产伦精品一区二区三区视频9| 麻豆av噜噜一区二区三区| 一进一出抽搐gif免费好疼| 亚洲精品影视一区二区三区av| 中文资源天堂在线| 国产一区二区三区在线臀色熟女| 波多野结衣巨乳人妻| 美女高潮喷水抽搐中文字幕| 亚洲天堂国产精品一区在线| 亚洲成人中文字幕在线播放| xxxwww97欧美| av在线观看视频网站免费| 国产淫片久久久久久久久| 国产白丝娇喘喷水9色精品| 亚洲av一区综合| 免费一级毛片在线播放高清视频| 亚洲自偷自拍三级| 最近最新中文字幕大全电影3| 男人舔女人下体高潮全视频| 91精品国产九色| 午夜福利在线在线| 无人区码免费观看不卡| 老熟妇仑乱视频hdxx| 俺也久久电影网| 人妻制服诱惑在线中文字幕| 69人妻影院| 国产精品不卡视频一区二区| 舔av片在线| 免费一级毛片在线播放高清视频| 国产一区二区在线av高清观看| 老师上课跳d突然被开到最大视频| 欧美日韩精品成人综合77777| 韩国av在线不卡| 91久久精品电影网| 真人一进一出gif抽搐免费| 女同久久另类99精品国产91| 日韩欧美精品免费久久| av天堂中文字幕网| 久久久久国内视频| 国产亚洲精品久久久久久毛片| 久久6这里有精品| 国产精品亚洲美女久久久| 91久久精品国产一区二区三区| 亚洲欧美日韩高清在线视频| 长腿黑丝高跟| 窝窝影院91人妻| 亚洲熟妇中文字幕五十中出| 亚洲在线自拍视频| 国产欧美日韩精品亚洲av| 最近最新中文字幕大全电影3| 婷婷六月久久综合丁香| 欧美高清性xxxxhd video| 国产 一区精品| 麻豆精品久久久久久蜜桃| 久久热精品热| 可以在线观看的亚洲视频| 久久香蕉精品热| 嫩草影院入口| 欧美区成人在线视频| 国产精品久久视频播放| 麻豆成人av在线观看| 丝袜美腿在线中文| 波野结衣二区三区在线| 日韩欧美精品免费久久| 全区人妻精品视频| 97热精品久久久久久| 国产白丝娇喘喷水9色精品| 成人午夜高清在线视频| 网址你懂的国产日韩在线| 亚洲av熟女| 内射极品少妇av片p| 黄色视频,在线免费观看| 国产亚洲精品综合一区在线观看| 18禁在线播放成人免费| 日韩国内少妇激情av| 99九九线精品视频在线观看视频| 伦精品一区二区三区| 偷拍熟女少妇极品色| 日日摸夜夜添夜夜添av毛片 | 国产白丝娇喘喷水9色精品| 99国产精品一区二区蜜桃av| 少妇高潮的动态图| 一区二区三区免费毛片| 亚洲国产高清在线一区二区三| 俺也久久电影网| 在线天堂最新版资源| 国产成人影院久久av| 女同久久另类99精品国产91| 国产亚洲精品久久久com| 亚洲电影在线观看av| 亚洲欧美清纯卡通| 欧美日韩黄片免| 好男人在线观看高清免费视频| 国产午夜福利久久久久久| 给我免费播放毛片高清在线观看| 不卡一级毛片| 日韩 亚洲 欧美在线| 男女啪啪激烈高潮av片| 国产亚洲欧美98| 午夜影院日韩av| 女人被狂操c到高潮| 久久国产乱子免费精品| 内地一区二区视频在线| 色吧在线观看| 联通29元200g的流量卡| a级毛片a级免费在线| 91在线观看av| 一夜夜www| 日韩精品中文字幕看吧| 久久久久国内视频| 人妻夜夜爽99麻豆av| 国产人妻一区二区三区在| 国产免费一级a男人的天堂| 别揉我奶头~嗯~啊~动态视频| 悠悠久久av| bbb黄色大片| 欧美+亚洲+日韩+国产| 在线看三级毛片| 亚洲精品一区av在线观看| 女人被狂操c到高潮| 亚洲精品成人久久久久久| 精品午夜福利视频在线观看一区| 五月伊人婷婷丁香| av黄色大香蕉| 哪里可以看免费的av片| 欧美日本视频| 成人午夜高清在线视频| 在线观看免费视频日本深夜| 日本黄色片子视频| eeuss影院久久| 99热这里只有精品一区| 亚洲一级一片aⅴ在线观看| 日本一本二区三区精品| 亚洲精品粉嫩美女一区| 韩国av一区二区三区四区| 亚洲av一区综合| 国产精品国产高清国产av| 亚洲五月天丁香| 成人特级黄色片久久久久久久| 日本欧美国产在线视频| 日韩欧美国产一区二区入口| 久久久国产成人精品二区| 少妇丰满av| av黄色大香蕉| 国产一区二区在线av高清观看| 日韩欧美在线乱码| а√天堂www在线а√下载| 亚洲经典国产精华液单| 一本一本综合久久| av天堂在线播放| 欧美色欧美亚洲另类二区| 麻豆成人av在线观看| 观看美女的网站| 十八禁国产超污无遮挡网站| 成人三级黄色视频| 国产麻豆成人av免费视频| 亚洲中文字幕一区二区三区有码在线看| 亚洲国产精品成人综合色| 久久久久久久久久成人| 女生性感内裤真人,穿戴方法视频| 精品久久久久久久久久久久久| 精品久久久久久,| 国产成人aa在线观看| 国产亚洲精品久久久久久毛片| 亚洲aⅴ乱码一区二区在线播放| 免费av观看视频| 亚洲国产欧美人成| 人妻丰满熟妇av一区二区三区| 国产伦精品一区二区三区视频9| 男人狂女人下面高潮的视频| 久久欧美精品欧美久久欧美| 美女cb高潮喷水在线观看| 老熟妇乱子伦视频在线观看| 我要搜黄色片| netflix在线观看网站| 国产精品日韩av在线免费观看| 国产色爽女视频免费观看| 亚洲四区av| 亚洲电影在线观看av| 亚洲最大成人手机在线| av天堂在线播放| 成人亚洲精品av一区二区| 我的女老师完整版在线观看| 国产激情偷乱视频一区二区| 亚洲七黄色美女视频| 99视频精品全部免费 在线| 国产人妻一区二区三区在| 午夜影院日韩av| 国产久久久一区二区三区| 亚洲自偷自拍三级| 久久久久免费精品人妻一区二区| 国产精品久久久久久av不卡| 国产女主播在线喷水免费视频网站 | 亚洲成a人片在线一区二区| www日本黄色视频网| 中文字幕人妻熟人妻熟丝袜美| 国产黄a三级三级三级人| 成人欧美大片| 一个人免费在线观看电影| 又紧又爽又黄一区二区| 99在线视频只有这里精品首页| 精品人妻1区二区| 99热这里只有精品一区| 久久精品影院6| 亚洲,欧美,日韩| 欧美成人一区二区免费高清观看| 国产精品综合久久久久久久免费| 国产精品久久久久久久久免| 免费电影在线观看免费观看| 人人妻人人看人人澡| 91久久精品国产一区二区成人| 国产熟女欧美一区二区| 国产美女午夜福利| 午夜福利欧美成人| 啦啦啦观看免费观看视频高清| 深爱激情五月婷婷| 国产熟女欧美一区二区| 国内精品久久久久久久电影| 久久这里只有精品中国| a级一级毛片免费在线观看| 一区二区三区四区激情视频 | 婷婷精品国产亚洲av| 1024手机看黄色片| 深夜a级毛片| 观看免费一级毛片| 美女xxoo啪啪120秒动态图| 网址你懂的国产日韩在线| 麻豆成人午夜福利视频| 3wmmmm亚洲av在线观看| 亚洲在线观看片| 免费看美女性在线毛片视频| 国产精品久久久久久久电影| 99热这里只有是精品在线观看| 久久久成人免费电影| 国产在线男女| 国产精品久久久久久av不卡| 中文字幕av成人在线电影| 亚洲avbb在线观看| 99在线人妻在线中文字幕| 熟妇人妻久久中文字幕3abv| 嫁个100分男人电影在线观看| 日本五十路高清| 99久久成人亚洲精品观看| 欧美性猛交黑人性爽| h日本视频在线播放| 可以在线观看的亚洲视频| 男女下面进入的视频免费午夜| 联通29元200g的流量卡| 女人十人毛片免费观看3o分钟| 成人特级黄色片久久久久久久| 成年免费大片在线观看| 久久久久久久久久黄片| 欧美绝顶高潮抽搐喷水| 亚洲欧美清纯卡通| 日韩欧美精品v在线| 亚洲av成人精品一区久久| 少妇裸体淫交视频免费看高清| 亚洲成人免费电影在线观看| 欧美丝袜亚洲另类 | 美女被艹到高潮喷水动态| 欧美激情在线99| 免费在线观看影片大全网站| 成熟少妇高潮喷水视频| 亚洲国产欧美人成| av福利片在线观看| 精品无人区乱码1区二区| 一进一出好大好爽视频| av在线亚洲专区| 禁无遮挡网站| 美女免费视频网站| 日韩一区二区视频免费看| 欧美zozozo另类| 悠悠久久av| 亚洲久久久久久中文字幕| 琪琪午夜伦伦电影理论片6080| 一个人看的www免费观看视频| 一进一出抽搐动态| 色综合亚洲欧美另类图片| 91在线观看av| 国产亚洲精品久久久com| 美女大奶头视频| 联通29元200g的流量卡| 夜夜爽天天搞| 婷婷精品国产亚洲av在线| 老师上课跳d突然被开到最大视频| 欧美一区二区亚洲| 色哟哟哟哟哟哟| 一卡2卡三卡四卡精品乱码亚洲| 国国产精品蜜臀av免费| 精品不卡国产一区二区三区| 亚洲一区高清亚洲精品| 天堂√8在线中文| 99久久九九国产精品国产免费| 精品人妻熟女av久视频| 久久99热这里只有精品18| 搡老熟女国产l中国老女人| 免费观看的影片在线观看| 亚洲成人中文字幕在线播放| 国产伦精品一区二区三区四那| 色播亚洲综合网| 亚洲精品在线观看二区| 十八禁国产超污无遮挡网站| 国产高清有码在线观看视频| 久久热精品热| 国产大屁股一区二区在线视频| 18禁在线播放成人免费| 三级国产精品欧美在线观看| 日韩欧美在线二视频| 极品教师在线免费播放| 亚洲中文字幕一区二区三区有码在线看| 老司机福利观看| 国产精品爽爽va在线观看网站| av.在线天堂| 欧美日韩亚洲国产一区二区在线观看| 国产一区二区激情短视频| 又紧又爽又黄一区二区| 成人二区视频| 麻豆国产97在线/欧美| 亚洲专区国产一区二区| 欧美中文日本在线观看视频| 床上黄色一级片| 女同久久另类99精品国产91| 亚洲精品456在线播放app | 日韩精品中文字幕看吧| 精品无人区乱码1区二区| 日本精品一区二区三区蜜桃| 黄色配什么色好看| 99热6这里只有精品| 国产精品免费一区二区三区在线| 亚洲国产精品合色在线| 午夜激情福利司机影院| 我的女老师完整版在线观看| 看免费成人av毛片| aaaaa片日本免费| 国产av不卡久久| 在线a可以看的网站| 成人鲁丝片一二三区免费|